Fundz
A company that just raised surges hiring in 30 to 60 days. Fundz shows you the money, about a month before the job ad.See it live →

Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer

PRIVATESep 17, 2026•about 2 hours ago

Position

Chief Medical Officer

Company

Paradigm Biopharmaceuticals

Dr Daniel Furtner
MelbourneBiotechnologyHealth CareTherapeutics

Description

Paradigm Biopharmaceuticals has appointed Dr Daniel Furtner as its new Chief Medical Officer. He succeeds Dr Donna Skerrett, who will remain with the company as Senior Scientific Advisor.

Company Information

Company

Paradigm Biopharmaceuticals

Location

Melbourne, Victoria, Australia

About

Paradigm Biopharmaceuticals is a Melbourne-based biotechnology company focused on innovative treatments for patients with osteoarthritis. They are currently advancing their Phase 3 clinical trial and preparing for regulatory submissions. The company aims to improve the quality of life for individuals affected by joint diseases.

Don't miss Paradigm Biopharmaceuticals's next move

Get an email the moment Paradigm Biopharmaceuticals changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Paradigm Biopharmaceuticals's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Paradigm Biopharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.